Literature DB >> 30049642

Multivariable analysis of predictors of unplanned hospital readmission after pancreaticoduodenectomy: development of a validated risk score.

Amanda P C S Boteon1, Yuri L Boteon1, James Hodson2, Helen Osborne1, John Isaac1, Ravi Marudanayagam1, Darius F Mirza1, Paolo Muiesan1, John K Roberts1, Robert P Sutcliffe3.   

Abstract

BACKGROUND: Unplanned hospital readmission after pancreaticoduodenectomy (PD) is usually due to surgical complications and has significant clinical and economic impact. This study developed a risk score to predict 30-day readmission after PD.
METHODS: Patients undergoing PD between 2009 and 2016 were reviewed from a prospective database. Predictors of readmission were identified using a multivariable logistic regression model, from which a points-based risk scoring system was derived.
RESULTS: 81 of 518 patients (15.6%) were readmitted within 30 days. History of cardiac disease ([odds ratio] OR = 2.12; 95% CI: 1.12-4.56), CRP>140 mg/L on post-operative day 3 (OR = 2.34; 95% CI: 1.37-4.35) and comprehensive complication index >14 (OR = 1.74; 95% CI: 1.03-2.85) were independent predictors of readmission. The regression coefficients were used to generate a risk score with excellent calibration (p = 0.917) and good discrimination (c-index = 0.65; 95% CI: 0.58-0.71; p < 0.001). Patients were categorised as low, moderate and high risk, with readmission rates of 6.4%, 13.4% and 23.0% respectively (p < 0.001).
CONCLUSION: The risk score identifies patients at high risk of readmission after pancreaticoduodenectomy. Such patients may benefit from pre-discharge imaging and/or enhanced follow-up, which may potentially reduce the impact of readmissions.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2018        PMID: 30049642     DOI: 10.1016/j.hpb.2018.06.1802

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  4 in total

1.  Diagnostic value of C-reactive protein and procalcitonin for postoperative pancreatic fistula following pancreatoduodenectomy: a systematic review and meta-analysis.

Authors:  Guoli Chen; Haizhao Yi; Jinguang Zhang
Journal:  Gland Surg       Date:  2021-12

2.  Outcome after implementation of a clinical pathway for pancreaticoduodenectomy in a low volume centre.

Authors:  Thomas Zacharias; Dan Sebastien; Ferreira Nelio
Journal:  Contemp Oncol (Pozn)       Date:  2022-06-20

3.  Early vs Late Readmissions in Pancreaticoduodenectomy Patients: Recognizing Comprehensive Episodic Cost to Help Guide Bundled Payment Plans and Hospital Resource Allocation.

Authors:  Alexandra W Acher; James R Barrett; Patrick B Schwartz; Chris Stahl; Taylor Aiken; Sean Ronnekleiv-Kelly; Rebecca M Minter; Glen Leverson; Sharon Weber; Daniel E Abbott
Journal:  J Gastrointest Surg       Date:  2020-07-15       Impact factor: 3.452

4.  The Severity of Postoperative Pancreatic Fistula Predicts 30-Day Unplanned Hospital Visit and Readmission after Pancreaticoduodenectomy: A Single-Center Retrospective Cohort Study.

Authors:  Hao-Wei Kou; Chih-Po Hsu; Yi-Fu Chen; Jen-Fu Huang; Shih-Chun Chang; Chao-Wei Lee; Shang-Yu Wang; Chun-Nan Yeh; Ta-Sen Yeh; Tsann-Long Hwang; Jun-Te Hsu
Journal:  Healthcare (Basel)       Date:  2022-01-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.